Ligand Pharmaceuticals Inc
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Ligand Pharmaceuticals Inc Corporate, CUSIP 53220KAE8.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Ligand Pharmaceuticals Inc Corporate, CUSIP 53220KAE8.